NO20011087D0 - Farmasøytiske preparater inneholdende kalsiumvalproat med forsinket frisetting av aktiv bestanddel samt fremgangsmÕte for fremstilling derav - Google Patents

Farmasøytiske preparater inneholdende kalsiumvalproat med forsinket frisetting av aktiv bestanddel samt fremgangsmÕte for fremstilling derav

Info

Publication number
NO20011087D0
NO20011087D0 NO20011087A NO20011087A NO20011087D0 NO 20011087 D0 NO20011087 D0 NO 20011087D0 NO 20011087 A NO20011087 A NO 20011087A NO 20011087 A NO20011087 A NO 20011087A NO 20011087 D0 NO20011087 D0 NO 20011087D0
Authority
NO
Norway
Prior art keywords
preparation
active ingredient
pharmaceutical preparations
delayed release
containing calcium
Prior art date
Application number
NO20011087A
Other languages
English (en)
Other versions
NO20011087L (no
Inventor
Dagmar GOEBEL
Michael Pieroth
Bernd Terhaag
Ramona Dieckmann
Evelyn Heuberger-Wieland
Original Assignee
Dresden Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dresden Arzneimittel filed Critical Dresden Arzneimittel
Publication of NO20011087D0 publication Critical patent/NO20011087D0/no
Publication of NO20011087L publication Critical patent/NO20011087L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20011087A 1998-09-03 2001-03-02 Farmasöytiske preparater inneholdende kalsiumvalproat med forsinket frisetting av aktiv bestanddel samt fremgangsmåte forfremstilling derav NO20011087L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19840152A DE19840152A1 (de) 1998-09-03 1998-09-03 Calciumvalproat enthaltende pharmazeutische Zusammensetzungen mit retardierter Wirkstoff-Freisetzung, Verfahren zu deren Herstellung und deren Verwendung
PCT/EP1999/006490 WO2000013711A1 (de) 1998-09-03 1999-09-03 Calciumvalproat enthaltende pharmazeutische zusammensetzungen mit retardierter wirkstoff-freisetzung und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
NO20011087D0 true NO20011087D0 (no) 2001-03-02
NO20011087L NO20011087L (no) 2001-05-02

Family

ID=7879672

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011087A NO20011087L (no) 1998-09-03 2001-03-02 Farmasöytiske preparater inneholdende kalsiumvalproat med forsinket frisetting av aktiv bestanddel samt fremgangsmåte forfremstilling derav

Country Status (12)

Country Link
US (1) US20020052411A1 (no)
EP (1) EP1107792A1 (no)
AU (1) AU5859799A (no)
BG (1) BG105276A (no)
CZ (1) CZ2001753A3 (no)
DE (1) DE19840152A1 (no)
EA (1) EA002695B1 (no)
HU (1) HUP0201625A2 (no)
NO (1) NO20011087L (no)
PL (1) PL346474A1 (no)
SK (1) SK2592001A3 (no)
WO (1) WO2000013711A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK13252002A3 (sk) * 2000-03-08 2003-07-01 Awd. Pharma Gmbh & Co. Kg Farmaceutické prípravky
JP2007500770A (ja) * 2003-07-28 2007-01-18 マリンクロッド・インコーポレイテッド 改善されたステアレート組成物およびその製法
BRPI0615860B8 (pt) * 2005-09-09 2021-05-25 Labopharm Barbados Ltd composição farmacêutica de liberação prolongada monolítica sólida
US20070160960A1 (en) * 2005-10-21 2007-07-12 Laser Shot, Inc. System and method for calculating a projectile impact coordinates
WO2008010800A1 (en) * 2006-07-19 2008-01-24 President And Fellows Of Harvard College Par-4 related methods and compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981000562A1 (en) * 1979-08-20 1981-03-05 Abbott Lab Mixed salt of valproic acid
IL72381A (en) * 1983-07-20 1988-03-31 Sanofi Sa Pharmaceutical composition based on valproic acid
CA1242738A (en) * 1983-10-26 1988-10-04 Abbott Laboratories Acid salts of valproic acid
NL8600050A (nl) * 1986-01-13 1987-08-03 Sanico Nv Farmaceutisch preparaat met vertraagde afgifte van het werkzame bestanddeel en werkwijze voor de bereiding er van.
JPS63101320A (ja) * 1986-10-17 1988-05-06 Dainippon Pharmaceut Co Ltd バルプロ酸カルシウム製剤
DE3709230A1 (de) * 1987-03-20 1988-10-06 Desitin Arzneimittel Gmbh Neues calciumsalz der valproinsaeure
DD295543A5 (de) * 1987-11-26 1991-11-07 Univ Halle Wittenberg Verfahren zur herstellung einer ca-valproat-arzneiform mit gleichmaessig verzoegerter wirkstofffreisetzung
FR2643556B1 (fr) * 1989-02-27 1993-03-05 Sanofi Sa Composition pharmaceutique a liberation prolongee d'acide valproique
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy

Also Published As

Publication number Publication date
EP1107792A1 (de) 2001-06-20
WO2000013711A1 (de) 2000-03-16
SK2592001A3 (en) 2001-11-06
AU5859799A (en) 2000-03-27
BG105276A (en) 2001-11-30
HUP0201625A2 (en) 2002-09-28
EA200100309A1 (ru) 2001-08-27
NO20011087L (no) 2001-05-02
CZ2001753A3 (cs) 2001-08-15
DE19840152A1 (de) 2000-03-09
EA002695B1 (ru) 2002-08-29
US20020052411A1 (en) 2002-05-02
PL346474A1 (en) 2002-02-11

Similar Documents

Publication Publication Date Title
NO308107B1 (no) Ikke-solvatert krystallinsk forbindelse, farmasøytisk formulering inneholdende denne samt anvendelse av forbindelsen for fremstilling av et farmasøytisk middel
DE69514192D1 (de) Arzneimittel und/oder Nahrungsmikrokapseln zur oralen Verabreichung
HUP0200618A3 (en) Oral pharmaceutical pulsed release dosage form and process for its preparation
MX9206236A (es) Composiciones farmaceuticas de liberacion controlada y proceso para su preparacion.
NL194577B (nl) Preparaat voor de lang aanhoudende en gecontroleerde afgifte van medicamenteuze stoffen.
DK98088A (da) Farmaceutisk formulering med forsinket frigivelse af den aktive bestanddel
NO993484L (no) Farmasöytisk preparat med regulert frigjöringsvirkning
DE19580261D2 (de) Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktion
IL139512A0 (en) Oral medicinal preparations with reproducible release of the active ingredient gatifloaxacin or its pharmaceutically suitable salts or hydrates
NO970610D0 (no) Sammensetning for selektiv frigjöring av en aktiv ingrediens
ATE220547T1 (de) Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
NO20006646L (no) Aminosyrederivater og legemidler inneholdende de samme som aktiv bestanddel
NO942303D0 (no) Farmasöytisk preparat, samt fremgangsmåte for fremstilling derav
FI972949A0 (fi) Lääkemuoto kollagenaasin vapauttamiseksi haavoihin ja sen valmistusmenetelmiä
NO975567D0 (no) Preparat med kontrollert frigivelse av aktiv substans
NO20011087D0 (no) Farmasøytiske preparater inneholdende kalsiumvalproat med forsinket frisetting av aktiv bestanddel samt fremgangsmÕte for fremstilling derav
DE69518193T2 (de) Präparat mit verzörgerter Wirkstoffabgabe
EE04095B1 (et) Ketoliidide ja nende farmatseutiliselt vastuvõetavate soolade kasutamine farmatseutiliste kompositsioonide valmistamiseks
NO305750B1 (no) Substituerte benzensulfonylureaer og deres anvendelse for fremstilling av farmas°ytiske preparater samt farmas°ytiske preparater inneholdende forbindelsene
FR2747307B1 (fr) Application a titre de medicament des ceramides et compositions notamment pharmaceutiques les renfermant
SE9802531D0 (sv) Pharmaceutical preparations and methods for treatment and/or prevention of intrauterine growth retardation
SI1077703T1 (en) Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates
ZA987799B (en) Pharmaceutical compositions for the controlled release of active substances
HUP9903342A3 (en) Use of cyclooxygenase-2 inhibitors for the preparation of pharmaceutical compositions treating and preventing angiogenic disorders
NO20012992L (no) Krystallinsk form av TRAP samt anvendelse derav for strukturbasert medikament-utforming